QLEIX | SRUIX | QLEIX / SRUIX | |
Total Expense Ratio | 5.33 | 1.51 | 353% |
Annual Report Gross Expense Ratio | 5.33 | 1.51 | 353% |
Fund Existence | 12 years | 9 years | - |
Gain YTD | 19.226 | 8.648 | 222% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 1000000 | 500% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.49B | 238M | 2,308% |
Annual Yield % from dividends | 6.11 | 0.96 | 634% |
Returns for 1 year | 30.05 | 4.26 | 705% |
Returns for 3 years | 106.01 | 21.55 | 492% |
Returns for 5 years | 185.56 | 41.90 | 443% |
Returns for 10 years | 150.39 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETHSX | 12.81 | 0.14 | +1.10% |
Eaton Vance Worldwide Health Sci A | |||
LMPMX | 39.14 | 0.01 | +0.03% |
ClearBridge Small Cap Growth 1 | |||
ACEIX | 11.01 | -0.03 | -0.27% |
Invesco Equity and Income A | |||
AMCGX | 10.95 | -0.03 | -0.27% |
Alger Mid Cap Growth B | |||
NBRVX | 26.42 | -0.11 | -0.41% |
Neuberger Berman M/C Intrinsic Val Inv |